Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate

Madhukiran H. Murthy, Michael E. Olson, Robert W. Wickert, Paul D Fey, Ziba Jalali

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin-resistant Staphylococcus aureus (MRSA). Our case is unique in the description of an MRSA USA 300 isolate that developed decreased susceptibility to daptomycin during daptomycin and vancomycin therapy. Directed sequencing detected a previously reported mutation in mprF, resulting in a T345A substitution, associated with non-susceptibility to daptomycin.

Original languageEnglish (US)
Pages (from-to)1036-1038
Number of pages3
JournalJournal of Medical Microbiology
Volume57
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Daptomycin
Methicillin
Staphylococcus aureus
Vancomycin
Mutation

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. / Murthy, Madhukiran H.; Olson, Michael E.; Wickert, Robert W.; Fey, Paul D; Jalali, Ziba.

In: Journal of Medical Microbiology, Vol. 57, No. 8, 01.08.2008, p. 1036-1038.

Research output: Contribution to journalArticle

Murthy, Madhukiran H. ; Olson, Michael E. ; Wickert, Robert W. ; Fey, Paul D ; Jalali, Ziba. / Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. In: Journal of Medical Microbiology. 2008 ; Vol. 57, No. 8. pp. 1036-1038.
@article{8df16ed46c1a46ca88eab1574a5a46d0,
title = "Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate",
abstract = "Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin-resistant Staphylococcus aureus (MRSA). Our case is unique in the description of an MRSA USA 300 isolate that developed decreased susceptibility to daptomycin during daptomycin and vancomycin therapy. Directed sequencing detected a previously reported mutation in mprF, resulting in a T345A substitution, associated with non-susceptibility to daptomycin.",
author = "Murthy, {Madhukiran H.} and Olson, {Michael E.} and Wickert, {Robert W.} and Fey, {Paul D} and Ziba Jalali",
year = "2008",
month = "8",
day = "1",
doi = "10.1099/jmm.0.2008/000588-0",
language = "English (US)",
volume = "57",
pages = "1036--1038",
journal = "Journal of Medical Microbiology",
issn = "0022-2615",
publisher = "Society for General Microbiology",
number = "8",

}

TY - JOUR

T1 - Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate

AU - Murthy, Madhukiran H.

AU - Olson, Michael E.

AU - Wickert, Robert W.

AU - Fey, Paul D

AU - Jalali, Ziba

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin-resistant Staphylococcus aureus (MRSA). Our case is unique in the description of an MRSA USA 300 isolate that developed decreased susceptibility to daptomycin during daptomycin and vancomycin therapy. Directed sequencing detected a previously reported mutation in mprF, resulting in a T345A substitution, associated with non-susceptibility to daptomycin.

AB - Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin-resistant Staphylococcus aureus (MRSA). Our case is unique in the description of an MRSA USA 300 isolate that developed decreased susceptibility to daptomycin during daptomycin and vancomycin therapy. Directed sequencing detected a previously reported mutation in mprF, resulting in a T345A substitution, associated with non-susceptibility to daptomycin.

UR - http://www.scopus.com/inward/record.url?scp=50249138332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50249138332&partnerID=8YFLogxK

U2 - 10.1099/jmm.0.2008/000588-0

DO - 10.1099/jmm.0.2008/000588-0

M3 - Article

C2 - 18628509

AN - SCOPUS:50249138332

VL - 57

SP - 1036

EP - 1038

JO - Journal of Medical Microbiology

JF - Journal of Medical Microbiology

SN - 0022-2615

IS - 8

ER -